... (ESRD) on dialysis who also must be treated for heart disease, stents provide the best one-year survival compared with other revascularization treatments, but bypass surgery provides the best long- ...
... establish better prediction of a person's risk for coronary heart disease and make appropriate changes in their treatment."
Brautbar and the Atherosclerosis Risk in Communities researchers followed ...
... (1) of the benefits of pay for performance schemes in the UK for the management of coronary heart disease, with a particular focus on ethnic differences, has just been published online in Springer's ...
Financial incentives for doctors can improve the management of coronary heart disease and reduce ethnic differences in quality of and access to care, according to public health experts in the UK.
As the connection between second-hand smoke and coronary heart disease (CHD) became clearer and legislation was passed to reduce such passive smoking, exposures have been reduced. Researchers have ...
... risk of coronary heart disease may have drug developers barking up the wrong treatment tree, according to the authors ... C-reactive protein causes coronary heart disease, even though a number of studies ...
... research suggests that C-reactive protein, an enticing target for scientists working on new treatments for coronary heart disease, may not have a role in causing the disease, even though it is a ...
... parts of the body are removed and re-attached to the heart to restore open blood flow when the natural ... really evolved" along with heart disease treatment since the heart bypass machines and restorative ...
... age groups have occurred in the presence of unprecedented availability of evidence-based heart disease treatment and even more worrisome because the trends do not yet reflect the effects of the ...
... step closer to a new generation of heart disease treatments that use human stem cells. Scientists ... already know a number of the genes that shape the heart later in its development. Murphy plans to start ...
ST. LOUIS, July 8 (UPI) -- U.S. researchers have shown mouse embryonic stem cells can build the heart, thereby moving science closer to heart disease treatments using human stem cells.
